157 related articles for article (PubMed ID: 10440908)
1. Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486.
Trendle MC; Leong T; Kyle RA; Katzmann JA; Oken MM; Kay NE; Van Ness BG; Greipp PR
Am J Hematol; 1999 Aug; 61(4):232-7. PubMed ID: 10440908
[TBL] [Abstract][Full Text] [Related]
2. The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma.
Papanikolaou X; Alapat D; Rosenthal A; Stein C; Epstein J; Owens R; Yaccoby S; Johnson S; Bailey C; Heuck C; Tian E; Joiner A; van Rhee F; Khan R; Zangari M; Jethava Y; Waheed S; Davies F; Morgan G; Barlogie B
Leukemia; 2015 Aug; 29(8):1713-20. PubMed ID: 25753926
[TBL] [Abstract][Full Text] [Related]
3. Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival.
Larsen JT; Chee CE; Lust JA; Greipp PR; Rajkumar SV
Blood; 2011 Sep; 118(10):2702-7. PubMed ID: 21750316
[TBL] [Abstract][Full Text] [Related]
4. A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.
Steensma DP; Gertz MA; Greipp PR; Kyle RA; Lacy MQ; Lust JA; Offord JR; Plevak MF; Therneau TM; Witzig TE
Blood; 2001 Apr; 97(8):2522-3. PubMed ID: 11290618
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma.
Greipp PR; Lust JA; O'Fallon WM; Katzmann JA; Witzig TE; Kyle RA
Blood; 1993 Jun; 81(12):3382-7. PubMed ID: 8507875
[TBL] [Abstract][Full Text] [Related]
6. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
Kumar S; Rajkumar SV; Greipp PR; Witzig TE
Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of bone marrow angiogenesis in multiple myeloma.
Rajkumar SV; Leong T; Roche PC; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle RA; Gertz MA; Greipp PR
Clin Cancer Res; 2000 Aug; 6(8):3111-6. PubMed ID: 10955791
[TBL] [Abstract][Full Text] [Related]
8. A new staging system for multiple myeloma based on the number of S-phase plasma cells.
San Miguel JF; García-Sanz R; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R
Blood; 1995 Jan; 85(2):448-55. PubMed ID: 7811998
[TBL] [Abstract][Full Text] [Related]
9. Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.
Fonseca R; Harrington D; Oken MM; Dewald GW; Bailey RJ; Van Wier SA; Henderson KJ; Blood EA; Rajkumar SV; Kay NE; Van Ness B; Greipp PR
Cancer Res; 2002 Feb; 62(3):715-20. PubMed ID: 11830525
[TBL] [Abstract][Full Text] [Related]
10. [Determination proliferative activity of myeloma cells in histologic material].
Fabian P; Kren L; Nenutil R
Cesk Patol; 2004 Apr; 40(2):46-9. PubMed ID: 15233016
[TBL] [Abstract][Full Text] [Related]
11. The significance of light chain-restricted bone marrow plasma cells after peripheral blood stem cell transplantation for multiple myeloma.
Maia DM; Kell DL; Goates JJ; Warnke RA
Am J Clin Pathol; 1997 Jun; 107(6):643-52. PubMed ID: 9169660
[TBL] [Abstract][Full Text] [Related]
12. Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?
Greipp PR; Trendle MC; Leong T; Oken MM; Kay NE; Van Ness B; Kyle RA
Leuk Lymphoma; 1999 Sep; 35(1-2):83-9. PubMed ID: 10512165
[TBL] [Abstract][Full Text] [Related]
13. Modified cIg-FISH protocol for multiple myeloma in routine cytogenetic laboratory practice.
Gole L; Lin A; Chua C; Chng WJ
Cancer Genet; 2014; 207(1-2):31-4. PubMed ID: 24485403
[TBL] [Abstract][Full Text] [Related]
14. Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.
Kourelis TV; Kumar SK; Gertz MA; Lacy MQ; Buadi FK; Hayman SR; Zeldenrust S; Leung N; Kyle RA; Russell S; Dingli D; Lust JA; Lin Y; Kapoor P; Rajkumar SV; McCurdy A; Dispenzieri A
J Clin Oncol; 2013 Dec; 31(34):4319-24. PubMed ID: 24145344
[TBL] [Abstract][Full Text] [Related]
15. Dual parameter analysis of myeloma cells by flow cytometry. DNA content of cells containing monotypic cytoplasmic immunoglobulin.
Chan CS; Wormsley SB; Peter JB; Schechter GP
Am J Clin Pathol; 1989 Jan; 91(1):12-7. PubMed ID: 2910012
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma or lymphoma? The increasing role of flow cytometry and serum-free light chain assay.
Mallik N; Nampoothiri RV; Sreedharanunni S; Singh Sachdeva MU; Malhotra P; Varma N
Indian J Pathol Microbiol; 2018; 61(1):149-150. PubMed ID: 29567910
[No Abstract] [Full Text] [Related]
17. Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group.
Greipp PR; Leong T; Bennett JM; Gaillard JP; Klein B; Stewart JA; Oken MM; Kay NE; Van Ness B; Kyle RA
Blood; 1998 Apr; 91(7):2501-7. PubMed ID: 9516151
[TBL] [Abstract][Full Text] [Related]
18. Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
Schambeck CM; Wick M; Bartl R; Lamerz R; Fateh-Moghadam A
J Clin Pathol; 1995 May; 48(5):477-81. PubMed ID: 7629298
[TBL] [Abstract][Full Text] [Related]
19. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.
Witzig TE; Gertz MA; Lust JA; Kyle RA; O'Fallon WM; Greipp PR
Blood; 1996 Sep; 88(5):1780-7. PubMed ID: 8781435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
